KALA BIO, Inc. — Director's Dealing 2025

Jan 11, 2025

SEC Form 4/A — Form 4/A

Issuer: KALA BIO, Inc. (KALA)
CIK: 0001479419
Period of Report: 2025-01-06

Reporting Person: Brazzell Romulus K (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	91636	Direct

Footnotes

F1: This amendment is being filed solely to amend the securities as beneficially owned by the reporting person following the transactions previously reported on January 7, 2025. On January 7, 2025, the reporting person filed a Form 4 which inadvertently reported that, following the grant of restricted units and a sale of common stock, the reporting person held 92,418 shares. As reported in this amendment, the reporting person directly owned 91,636 shares of common stock following the transactions, which included 62,961 unvested restricted stock units.